dr. coleman on rationale for using veliparib and chemotherapy in ovarian cancer
Published 5 years ago • 113 plays • Length 1:14Download video MP4
Download video MP3
Similar videos
-
1:55
rationale for chemotherapy plus veliparib in frontline treatment of ovarian cancers
-
2:12
dr. coleman on the use of veliparib in advanced ovarian cancer
-
5:40
combination veliparib and chemotherapy in ovarian cancer
-
2:03
dr. coleman on results of the velia trial in ovarian cancer
-
1:12
dr. coleman on next treatment steps for patients with ovarian cancer
-
3:29
dr. coleman on advances made in ovarian cancer treatment
-
1:13
dr. coleman on implications of the velia trial in ovarian cancer
-
1:25
robert l. coleman, md, facog, facs, on how veliparib factors into ovarian cancer treatment
-
0:16
copy of dr. coleman on classifying patients with ovarian cancer
-
1:59
dr. coleman on next steps following ariel2 trial for ovarian cancer
-
1:14
dr. coleman on classifying patients with ovarian cancer
-
33:15
ovarian cancer: standards of care and new opportunities - dr. robert coleman
-
4:37
velia/gog-3005 trial: veliparib for high-grade serous carcinoma of ovarian, fallopian tube, or p...
-
1:35
dr. coleman on immunotherapy in ovarian cancer
-
1:14
dr. coleman on benefit of rucaparib in ovarian cancer
-
1:13
dr. coleman on recent advances and remaining questions in ovarian cancer
-
1:04
dr. coleman on the velia trial impact on ovarian cancer practice
-
7:32
bevacizumab for recurrent ovarian cancer
-
1:41
dr. coleman on findings from the azure trial for breast cancer treatment